How are MANE butterfly max profit and max loss calculated?

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the MANE butterfly priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 100.80%), the computed maximum profit is $432.42 per contract and the computed maximum loss is -$50.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a MANE butterfly?

The breakeven for the MANE butterfly priced on this page is roughly $105.50 and $114.62 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The MANE market-implied 1-standard-deviation expected move in the same options snapshot is approximately 28.90%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current MANE implied volatility affect this butterfly?

Current MANE ATM IV is 100.80%; IV rank context is unavailable in the current snapshot.

MANE Butterfly Strategy

MANE (Veradermics, Incorporated), in the Healthcare sector, (Biotechnology industry), listed on NYSE.

Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis.

MANE (Veradermics, Incorporated) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $4.56B, a beta of 1.35 versus the broader market, a 52-week range of 32-131.24, average daily share volume of 689K, a public-listing history dating back to 2026, approximately 24 full-time employees. These structural characteristics shape how MANE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.35 indicates MANE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a butterfly on MANE?

A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.

MANE snapshot

As of August 14, 2026, spot at $111.50, ATM IV 100.80%, expected move 28.90%. The butterfly on MANE below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this butterfly structure on MANE specifically: IV rank is unavailable in the current snapshot, so regime-based timing for MANE is inferred from ATM IV at 100.80% alone, with a market-implied 1-standard-deviation move of approximately 28.90% (roughly $32.22 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MANE expiries trade a higher absolute premium for lower per-day decay. Position sizing on MANE should anchor to the underlying notional of $111.50 per share and to the trader's directional view on MANE stock.

MANE butterfly setup

The MANE butterfly below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MANE at $111.50 on that close, the first option leg uses a $105.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MANE chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MANE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$105.00	$16.90
Sell 2	Call	$110.00	$14.40
Buy 1	Call	$115.00	$12.40

MANE butterfly risk and reward

Net Premium / Debit: -$50.00
Max Profit (per contract): $432.42
Max Loss (per contract): -$50.00
Breakeven(s): $105.50, $114.62
Risk / Reward Ratio: 8.648

Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.

MANE butterfly payoff curve

Modeled P&L at expiration across a range of underlying prices for the butterfly on MANE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$50.00
$24.66	-77.9%	-$50.00
$49.31	-55.8%	-$50.00
$73.97	-33.7%	-$50.00
$98.62	-11.6%	-$50.00
$123.27	+10.6%	-$50.00
$147.92	+32.7%	-$50.00
$172.58	+54.8%	-$50.00
$197.23	+76.9%	-$50.00
$221.88	+99.0%	-$50.00

When traders use butterfly on MANE

Butterflies on MANE are pinning bets - traders use them when they expect MANE to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.

MANE thesis for this butterfly

The market-implied 1-standard-deviation range for MANE extends from approximately $79.28 on the downside to $143.72 on the upside. A MANE long call butterfly is a pinning play: it pays maximum at the middle strike if MANE settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. As a Healthcare name, MANE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MANE-specific events.

MANE butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MANE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MANE alongside the broader basket even when MANE-specific fundamentals are unchanged. Always rebuild the position from current MANE chain quotes before placing a trade.

Frequently asked questions

What is a butterfly on MANE?: A butterfly on MANE is the butterfly strategy applied to MANE (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With MANE stock at $111.50 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed MANE chain strike and the premiums come straight from that session's bid/ask midpoint.
How are MANE butterfly max profit and max loss calculated?: Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the MANE butterfly priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 100.80%), the computed maximum profit is $432.42 per contract and the computed maximum loss is -$50.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MANE butterfly?: The breakeven for the MANE butterfly priced on this page is roughly $105.50 and $114.62 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The MANE market-implied 1-standard-deviation expected move in the same options snapshot is approximately 28.90%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a butterfly on MANE?: Butterflies on MANE are pinning bets - traders use them when they expect MANE to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
How does current MANE implied volatility affect this butterfly?: Current MANE ATM IV is 100.80%; IV rank context is unavailable in the current snapshot.